-
PurposeExpresses CAS9 and sgRNA for targeted counterselection in S. aureus
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 107192 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepCN-50
- Backbone size w/o insert (bp) 5750
- Total vector size (bp) 7788
-
Modifications to backboneAddition of EF2132 and tetR. Replacement of cat194 gene with ermC gene from pCN33. Replacement of pT181cop-634ts with E194ts replicon.
-
Vector typeBacterial Expression
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Growth instructionsErythromycin selection in S. aureus, Ampicillin selection in E. coli. Temperature sensitive replicon must be maintained at 32 degrees in S. aureus. Stable at 37 degrees in E. coli.
-
Copy numberHigh Copy
Gene/Insert 1
-
Gene/Insert nameCas9
-
SpeciesS pyogenes
-
Insert Size (bp)4297
- Promoter prab17
Cloning Information for Gene/Insert 1
- Cloning method Unknown
- 5′ sequencing primer None
- 3′ sequencing primer None (Common Sequencing Primers)
Gene/Insert 2
-
Gene/Insert namesgRNA
-
Insert Size (bp)324
- Promoter prab17
Cloning Information for Gene/Insert 2
- Cloning method Unknown
- 5′ sequencing primer None
- 3′ sequencing primer None (Common Sequencing Primers)
Resource Information
-
Articles Citing this Plasmid
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pCAS9counter was a gift from Steve Salipante (Addgene plasmid # 107192 ; http://n2t.net/addgene:107192 ; RRID:Addgene_107192) -
For your References section:
Efficient and Scalable Precision Genome Editing in Staphylococcus aureus through Conditional Recombineering and CRISPR/Cas9-Mediated Counterselection. Penewit K, Holmes EA, McLean K, Ren M, Waalkes A, Salipante SJ. MBio. 2018 Feb 20;9(1). pii: mBio.00067-18. doi: 10.1128/mBio.00067-18. 10.1128/mBio.00067-18 PubMed 29463653